Journal article · 2021 · Open access

Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis

John S. Barbieri, Joel M. Gelfand

JAMA Dermatology, 157(10), 1236 · Published 8 September 2021 · DOI 10.1001/jamadermatol.2021.3341

Open PDFView at the publisherCite this paper

In brief

“Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis” is a 2021 journal article by John S. Barbieri and Joel M. Gelfand, published in JAMA Dermatology. OpenAlex counts 47 citations as of 22 November 2026. It is open access: the full text is free to read at JAMA Dermatology.

Citations
47
Most cited in
2023 (11)
Field-weighted impact
2.36
References
7
Authors
2

Abstract

This cross-sectional study assesses patient-reported outcome measures as a complement to clinician-reported outcome measures in psoriasis treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Barbieri, J. S., & Gelfand, J. M. (2021). Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis. JAMA Dermatology, 157(10), 1236. https://doi.org/10.1001/jamadermatol.2021.3341

MLA 9

Barbieri, John S., and Joel M. Gelfand. “Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis.” JAMA Dermatology, vol. 157, no. 10, 2021, p. 1236. https://doi.org/10.1001/jamadermatol.2021.3341.

Chicago

Barbieri, John S. and Joel M. Gelfand. 2021. “Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis.” JAMA Dermatology 157 (10): 1236. https://doi.org/10.1001/jamadermatol.2021.3341.

Harvard

Barbieri, J. S. and Gelfand, J. M. (2021) ‘Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis’, JAMA Dermatology, 157(10), p. 1236. doi:10.1001/jamadermatol.2021.3341.

IEEE

J. S. Barbieri and J. M. Gelfand, “Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis,” JAMA Dermatology, vol. 157, no. 10, p. 1236, 2021, doi: 10.1001/jamadermatol.2021.3341.

BibTeX

@article{barbieri2021patient,
  title     = {{Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis}},
  author    = {Barbieri, John S. and Gelfand, Joel M.},
  journal   = {JAMA Dermatology},
  year      = {2021},
  volume    = {157},
  number    = {10},
  pages     = {1236},
  doi       = {10.1001/jamadermatol.2021.3341},
  url       = {https://doi.org/10.1001/jamadermatol.2021.3341}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202111
202266
20231111
20241010
20251010
202699

Its field-weighted citation impact is 2.36: it has been cited 2.36 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis

  • psoriasis
  • patient-reported outcome measures
  • clinician-reported outcome measures
  • psoriasis treatment outcomes

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Barbieri, J. S., & Gelfand, J. M. (2021). Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis. JAMA Dermatology, 157(10), 1236. https://doi.org/10.1001/jamadermatol.2021.3341

How many times has this paper been cited?

47 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at JAMA Dermatology: sign in and open the PDF from this page.

Who wrote this paper?

John S. Barbieri, Joel M. Gelfand.

What is the DOI of this paper?

10.1001/jamadermatol.2021.3341, permanently at https://doi.org/10.1001/jamadermatol.2021.3341. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.